ReviewCancer drug resistance (Alhambra, Calif.)2023

The clinical challenges of homologous recombination proficiency in ovarian cancer: from intrinsic resistance to new treatment opportunities.

Teresa Zielli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.